Is Summit Therapeutics, Inc. technically bullish or bearish?

Sep 23 2025 11:21 AM IST
share
Share Via
As of September 19, 2025, Summit Therapeutics, Inc. shows a neutral technical trend with mixed indicators, underperforming the S&P 500 in the past month and year, but significantly outperforming it over the 3- and 5-year periods.
As of 19 September 2025, the technical trend for Summit Therapeutics, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with a mix of indicators showing mild bearishness in the weekly and monthly MACD, KST, and Bollinger Bands, while the daily moving averages indicate a mildly bullish trend. The Dow Theory shows a mildly bullish stance on the monthly timeframe but no trend on the weekly.

In terms of performance, the stock has underperformed the S&P 500 over the past month and year, with returns of -27.10% and -21.69% respectively, compared to the S&P 500's 3.95% and 16.64%. However, it has significantly outperformed the benchmark over the 3-year and 5-year periods, with returns of 1491.67% and 482.32%.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News